Hikal announces successful USFDA insepction of its API and Intermediates manufacturing facility

At Jigani, Bangalore

Hikal announced that the Company's API and Intermediates manufacturing facility located at Jigani, Bangalore was recently inspected by the US FDA in compliance with their requirements. At the end of the successful inspection, the Company have been informed by the Investigator that zero 483 observations were issued. This was a routine inspection by the US FDA.

Powered by Capital Market - Live News